Official SEC submissions

AgomAb Therapeutics SEC Filings

Direct answer

AgomAb Therapeutics's latest SEC filing is 4.

It was filed on November 6, 2026, and 20 recent filings are available.
Each row links directly to the SEC document and filing index.

Get free AgomAb Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Recent SEC filings

4

Insider transaction

Filed:

Report date:

PRIMARY DOCUMENT

4

Insider transaction

Filed:

Report date:

PRIMARY DOCUMENT

6-K

Current report

Filed:

Report date:

FORM 6-K

4

Insider transaction

Filed:

Report date:

PRIMARY DOCUMENT

4

Insider transaction

Filed:

Report date:

PRIMARY DOCUMENT

4

Insider transaction

Filed:

Report date:

PRIMARY DOCUMENT

4

Insider transaction

Filed:

Report date:

PRIMARY DOCUMENT

6-K

Current report

Filed:

Report date:

FORM 6-K

4

Insider transaction

Filed:

Report date:

OWNERSHIP DOCUMENT

4

Insider transaction

Filed:

Report date:

OWNERSHIP DOCUMENT

6-K

Current report

Filed:

Report date:

FORM 6-K

6-K

Current report

Filed:

Report date:

FORM 6-K

6-K

Current report

Filed:

Report date:

FORM 6-K

6-K

Current report

Filed:

Report date:

6-K

6-K

Current report

Filed:

Report date:

FORM 6-K

6-K

Current report

Filed:

Report date:

FORM 6-K

6-K

Current report

Filed:

Report date:

FORM 6-K

20-F

Periodic report

Filed:

Report date:

FORM 20-F

6-K

Current report

Filed:

Report date:

FORM 6-K

6-K

Current report

Filed:

Report date:

FORM 6-K

Verified data

Recent filing categories
3
Recent filings
20
SEC CIK
0002020932
Latest filing date
November 6, 2026